P
PROK
ProKidney
1.800
-0.040-2.17%Opening14:54 07/09 EDT
OPEN/PREV CLOSE1.850/1.840
TODAY RANGE1.750-1.860
VOL994.81K
MARKET CAP543.71M
52 WEEK RANGE0.5916-7.13
AVG VOL (3M)1.15M
% TURNOVER0.33%
TURNOVER--
P/E (TTM)-3.4208
% RANGE5.98%
EPS(TTM)-0.5262
P/E(FORWARD)-3.6735
P/B-0.5309
BVPS-3.3905
DIVIDEND--
P/S600.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP194.66M
SHARES OUTSTANDING302.06M
NEXT EARNINGS--
FREE FLOAT108.14M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·06/30 14:01
AEVEX, Abivax, Watts Water Technologies And Other Big Stocks Moving Higher On Tuesday
Benzinga·06/29 12:11
Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
TipRanks·06/02 13:29
ProKidney appoints Kenneth Locke as chief technical officer
PUBT·06/02 12:06
ProKidney names Kenneth Locke chief technical officer
Reuters·06/02 12:00
PROKIDNEY APPOINTS KENNETH LOCKE AS CHIEF TECHNICAL OFFICER
Dow Jones·06/02 12:00
Press Release: ProKidney Appoints Kenneth Locke as Chief Technical Officer
TipRanks·05/29 21:12
ProKidney shareholders reaffirm board and auditor at 2026 meeting
Dow Jones·05/18 15:09
ProKidney Price Target Maintained With a $12.00/Share by HC Wainwright & Co.
Benzinga·05/18 14:59
HC Wainwright & Co. Reiterates Buy on ProKidney, Maintains $12 Price Target
Seeking Alpha·05/18 06:03
ProKidney GAAP EPS of -$0.14 beats by $0.01, revenue of $0.23M beats by $0.03M
TipRanks·05/15 16:20
ProKidney Highlights Progress in Pivotal Phase 3 CKD Trial
TipRanks·05/15 16:03
ProKidney reports Q1 EPS (14c), consensus (14c)
Same Industry
Name/Symbol
Change%
Price